Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T

References

1. 1.↵
   2. Brooks BR,
   3. Miller RG,
   4. Swash M, et al

   ; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–99 doi:10.1080/146608200300079536 pmid:11464847

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Ravits JM,
   3. La Spada AR

   . ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805–11 doi:10.1212/WNL.0b013e3181b6bbbd pmid:19738176

   Abstract/FREE Full Text
3. 3.↵
   2. Kiernan MC,
   3. Vucic S,
   4. Cheah BC, et al

   . Amyotrophic lateral sclerosis. Lancet 2011;377:942–55 doi:10.1016/S0140-6736(10)61156-7 pmid:21296405

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Eisen A,
   3. Swash M

   . Clinical neurophysiology of ALS. Clin Neurophysiol 2001;112:2190–201 doi:10.1016/S1388-2457(01)00692-7 pmid:11738189

   CrossRefPubMed
5. 5.↵
   2. de Carvalho M,
   3. Dengler R,
   4. Eisen A, et al

   . Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008;119:497–503 doi:10.1016/j.clinph.2007.09.143 pmid:18164242

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Kawamata T,
   3. Akiyama H,
   4. Yamada T, et al

   . Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140:691–707 pmid:1347673

   PubMedWeb of Science
7. 7.↵
   2. Kwan JY,
   3. Jeong SY,
   4. Van Gelderen P, et al

   . Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One 2012;7:e35241 doi:10.1371/journal.pone.0035241 pmid:22529995

   CrossRefPubMed
8. 8.↵
   2. Verstraete E,
   3. Veldink JH,
   4. Hendrikse J, et al

   . Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012;83:383–88 doi:10.1136/jnnp-2011-300909 pmid:21965521

   Abstract/FREE Full Text
9. 9.↵
   2. Schuster C,
   3. Kasper E,
   4. Machts J, et al

   . Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J Neurol 2013;260:2856–64 doi:10.1007/s00415-013-7083-z pmid:23996101

   CrossRefPubMed
10. 10.↵
    2. Walhout R,
    3. Westeneng HJ,
    4. Verstraete E, et al

    . Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 2015;86:288–94 doi:10.1136/jnnp-2013-306839 pmid:25121571

    Abstract/FREE Full Text
11. 11.↵
    2. Foerster BR,
    3. Welsh RC,
    4. Feldman EL

    . 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol 2013;9:513–24 doi:10.1038/nrneurol.2013.153 pmid:23917850

    CrossRefPubMed
12. 12.↵
    2. Filippi M,
    3. Agosta F,
    4. Abrahams S, et al

    ; European Federation of Neurological Societies. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol 2010;17:526–e20 doi:10.1111/j.1468-1331.2010.02951.x pmid:20136647

    CrossRefPubMed
13. 13.↵
    2. Cosottini M,
    3. Donatelli G,
    4. Costagli M, et al

    . High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2016;37:455–61 doi:10.3174/ajnr.A4562 pmid:26680464

    Abstract/FREE Full Text
14. 14.↵
    2. Yousry TA,
    3. Schmid UD,
    4. Alkadhi H, et al

    . Localization of the motor hand area to a knob on the precentral gyrus: a new landmark. Brain 1997;120:141–57 doi:10.1093/brain/120.1.141 pmid:9055804

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Penfield W,
    3. Rasmussen T

    . The Cerebral Cortex of Man: A Clinical Study of Localization of Function. New York: Macmillan; 1950
16. 16.↵
    2. Costagli M,
    3. Donatelli G,
    4. Biagi L, et al

    . Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin 2016;12:965–69 doi:10.1016/j.nicl.2016.04.011 pmid:27995062

    CrossRefPubMed
17. 17.↵
    2. Mochizuki Y,
    3. Mizutani T,
    4. Takasu T

    . Amyotrophic lateral sclerosis with marked neurological asymmetry: clinicopathological study. Acta Neuropathol 1995;90:44–50 doi:10.1007/BF00294458 pmid:7572078

    CrossRefPubMed
18. 18.↵
    2. Kassubek J,
    3. Unrath A,
    4. Huppertz HJ, et al

    . Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:213–20 doi:10.1080/14660820510038538 pmid:16319024

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Devine MS,
    3. Pannek K,
    4. Coulthard A, et al

    . Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis. Neuroimage Clin 2015;7:782–87 doi:10.1016/j.nicl.2015.03.006 pmid:25844330

    CrossRefPubMed
20. 20.↵
    2. Hallgren B,
    3. Sourander P

    . The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41–51 doi:10.1111/j.1471-4159.1958.tb12607.x pmid:13611557

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Bede P,
    3. Bokde A,
    4. Elamin M, et al

    . Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 2013;84:766–73 doi:10.1136/jnnp-2012-302674 pmid:23085933

    Abstract/FREE Full Text
22. 22.↵
    2. Ignjatović A,
    3. Stević Z,
    4. Lavrnić S, et al

    . Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J Magn Reson Imaging 2013;38:1472–79 doi:10.1002/jmri.24121 pmid:23564606

    CrossRefPubMed
23. 23.↵
    2. Adachi Y,
    3. Sato N,
    4. Saito Y, et al

    . Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 2015;25:443–51 doi:10.1111/jon.12127 pmid:24888543

    CrossRefPubMed
24. 24.↵
    2. Du G,
    3. Lewis MM,
    4. Styner M, et al

    . Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011;26:1627–32 doi:10.1002/mds.23643 pmid:21618607

    CrossRefPubMed
25. 25.↵
    2. Baudrexel S,
    3. Nürnberger L,
    4. Rüb U, et al

    . Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease. Neuroimage 2010;51:512–20 doi:10.1016/j.neuroimage.2010.03.005 pmid:20211271

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Schweser F,
    3. Deistung A,
    4. Lehr BW, et al

    . Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54:2789–807 doi:10.1016/j.neuroimage.2010.10.070 pmid:21040794

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Barbosa JH,
    3. Santos AC,
    4. Tumas V, et al

    . Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging 2015;33:559–65 doi:10.1016/j.mri.2015.02.021 pmid:25721997

    CrossRefPubMed